Product Information
XTAMPZA ER 18 MG CAPSULE is a brand product labeled by Collegium Pharmaceutical, Inc., priced at $11.3961 per EA under NDC 24510012010. Its NADAC has been published 394 times since Jun 21, 2017.
Strength
18 mg/1
Manufacturer
Collegium Pharmaceutical, Inc.NDC
24510012010
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
12/18/2024
Active Ingredients
OXYCODONEApproval Type
New Drug (NDA)
FDA Application
NDA208090On Market Since
5/10/2016
Pharmacological Classes
Price Statistics
The NADAC for XTAMPZA ER 18 MG CAPSULE has been published 394 times since Jun 21, 2017, and over the history we have for it it has risen 72.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.3961 per EA |
|---|---|
| All-time high | $11.4316 (May 15, 2024) |
| All-time low | $6.6023 (Jun 21, 2017) |
| Median price | $9.6564 |
| Average price | $9.3444 |
| Largest weekly change | +9.9% (Dec 30, 2020) |
| Weeks tracked | 394 |
| Tracking since | Jun 21, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the OXYCODONE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of XTAMPZA ER 18 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for XTAMPZA ER 18 MG CAPSULE, manufactured by Collegium Pharmaceutical, Inc., is $11.3961 per EA (NDC 24510012010), effective Jan 1, 2025.
How has the price of XTAMPZA ER 18 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for XTAMPZA ER 18 MG CAPSULE has risen 72.6%. It has been tracked across 394 weekly CMS publications since Jun 21, 2017.
What are the highest and lowest recorded NADAC prices for XTAMPZA ER 18 MG CAPSULE?
Since Jun 21, 2017, the NADAC for XTAMPZA ER 18 MG CAPSULE has ranged from a low of $6.6023 (Jun 21, 2017) to a high of $11.4316 (May 15, 2024), with a median of $9.6564 per EA.
Are there cheaper alternatives to XTAMPZA ER 18 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of XTAMPZA ER 18 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures XTAMPZA ER 18 MG CAPSULE?
XTAMPZA ER 18 MG CAPSULE (NDC 24510012010) is labeled by Collegium Pharmaceutical, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification